Community Research Initiative of New England
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Community Research Initiative of New England sits in the top decile of US sponsors by registered trial count (#1,458 of 15,751 sponsors by registered trial count).
Community Research Initiative of New England: 9 sponsored US clinical trials, none currently recruiting.
Community Research Initiative of New England sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 6 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 3 trials.
Top-decile sponsor footprint
Community Research Initiative of New England ranks in the top decile of sponsors by registered trial count (#1,458 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
NCT03235154
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
NCT00931801
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
NCT00756730
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
NCT00751530
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
NCT00543101
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
NCT00414635
BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
NCT00414284
An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
NCT00002091
A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
NCT00002092
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 6 |
Therapeutic Areas
How the Community Research Initiative of New England archive is shaped
9 indexed studies, none listed as recruiting (0% open); 8 completed (89%).
Phase mix: 6 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: HIV Infections (3 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.